Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma - Pinato, D; Brown, M; Trousil, S; Aboagye, E; Beaumont, J; Zhang, H; Coley, H; Mauri, F; Sharma, R (Springer Nature, 2019)